National Veterinary Care Ltd rises 7.5% to an all-time high

National Veterinary Care Ltd (ASX:NVL) is barking up the right tree.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

National Veterinary Care Ltd (ASX: NVL) rose by 7.53% today and 4.29% yesterday. The share price has more than doubled since it listed in August 2015 and I think it could go on to grow into a sizeable business.

The business has been on a steady acquisition spree since it first listed and recently announced that it will be acquiring four more clinics that will add $4.5 million of revenue and $0.79 million of earnings before interest and tax over a 12 month period. Management expect that these clinics will be earnings per share (EPS) accretive in FY18.

The pet industry is a good one to operate in with a growing pet population, humanisation of pets and increased take-up of pet insurance. Around three quarters of dogs and two thirds of cats go to a vet each year. All of these factors were major reasons why general practice organic growth was 4.2% in FY17.

The wellness program called 'best for pet' has been very successful for National Vet Care. It now has around 14,000 members which represents growth of about 30% since 1 July 2017. Members' average spend reportedly increases by 94% after joining the program.

National Vet Care reported that it generated 8.46 cents basic EPS and 11.38 cents underlying EPS in FY17. The difference between these two figures is the acquisition and other one-off costs. This suggests that with no other acquisitions in FY18 it would have shown growth EPS growth of around 34%.

However, management have predicted that statutory revenue will likely grow by at least 25% in FY18, which means that FY18 could be another bumper year for the company.

Foolish takeaway

National Vet Care is currently trading at 28x FY17's underlying earnings, which I think is a reasonable price to pay for a business that may grow at a strong rate over the next few years.

Motley Fool contributor Tristan Harrison owns shares of NATVETCARE FPO. The Motley Fool Australia owns shares of NATVETCARE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »